fluorodopa F 18: Clinical Trials

12 trials of fluorodopa F 18, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 recruiting, 1 active not recruiting, 1 enrolling by invitation. 12 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 212Completed 7, Recruiting 3, Active not recruiting 1, Enrolling by invitation 1

Follow fluorodopa F 18: new trials by email Literature Review of fluorodopa F 18 trials Research Report on fluorodopa F 18

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
Computed Tomography, Fluorodopa F 18, Positron Emission Tomography - Malignant Brain Neoplasm
Phase 2RecruitingMayo Clinic472026-03-242026-04-28
Ultralow Dose PET Imaging of 18F-FDOPA
18F-FDOPA - Heathy Volunteer, Parkinsonian Syndromes
Phase 2Enrolling by invitationAkiva Mintz2002025-05-122026-04-21
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
Accelerated Hypofractionated Radiation Therapy, Computed Tomography, Fluorodopa F 18 - Glioblastoma
Phase 2Active not recruitingMayo Clinic1702023-03-232026-07-30
Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
18F-Fluoro Dopa PET/MRI Imaging - Hyperinsulinism
Phase 2RecruitingWashington University School of Medicine1002020-09-102025-12-19
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
Computed Tomography, Fluorodopa F 18, Magnetic Resonance Imaging - Glioblastoma, Malignant Glioma
Phase 2CompletedMayo Clinic432019-03-282025-07-03
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
Fluorine F 18 Fluorodopa, Intensity-Modulated Radiation Therapy, Positron Emission Tomography - Glioma
Phase 2CompletedMayo Clinic212017-09-292023-03-14
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
DOTATATE PET-CT, F-DOPA PET CT, CT scan - ACTH, Cushing's Syndrome
Phase 2RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)802014-02-122026-10-02
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Diffusion Weighted Imaging, Fluorine F 18 Fluorodopa, Intensity-Modulated Radiation Therapy - Malignant Glioma
Phase 2CompletedMayo Clinic912013-12-012025-10-20
Phase II Safety and Efficacy Study of 18FDOPA PET-CT in Children With Hyperinsulinemic Hypoglycemia
18 F-DOPA - Congenital Hyperinsulinism (CHI), Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Phase 2CompletedChildren's Hospital of Philadelphia1302009-01-012022-10-13
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
F-DOPA, PET scan - Congenital Hyperinsulinism, Hyperinsulinism
Phase 2CompletedChildren's Hospital of Philadelphia1062004-12-012022-11-09
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Pentetreotide, 18F-DOPA, CT scan - Cushing Syndrome, Endocrine Disease
Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)951999-05-202021-04-14
Studies of Elevated Parathyroid Activity
68Ga-Dotatate, 18F-DOPA - Hyperparathyroidism, Hypercalcemia
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)15531993-12-152022-06-07

Conditions studied

Glioma (4)  ·  Hyperinsulinism (3)  ·  Congenital Hyperinsulinism (2)  ·  Cushing Syndrome (2)  ·  Glioblastoma (2)  ·  Hypoglycemia (2)  ·  Brain Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hypercalcemia (1)  ·  Hyperparathyroidism (1)  ·  Infant, Newborn, Diseases (1)  ·  Insulinoma (1)  ·  Multiple Endocrine Neoplasia (1)  ·  Neoplasms (1)

Sponsors

Mayo Clinic (5)  ·  Children's Hospital of Philadelphia (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  Akiva Mintz (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Washington University School of Medicine (1)

Countries

United States (12)

Top investigators

Lisa J States, MD (2)  ·  Lynnette K Nieman, M.D. (2)  ·  Ana Maria Arbelaez, MD, MSCI (1)  ·  Debra H. Brinkmann, Ph.,D. (1)  ·  Derek R. Johnson, MD (1)  ·  Nadia N Laack (1)  ·  Nadia N. Laack, M.D. (1)  ·  Roman O. Kowalchuk, MD (1)  ·  Smita Jha, M.D. (1)  ·  Sujay A Vora (1)  ·  William G. Breen, MD (1)

Results publications

PMID 39571596, PMID 17236890, PMID 17895314, PMID 23414871, PMID 24314195, PMID 24314196, PMID 33771703